Соединенные Штаты - английский - NLM (National Library of Medicine)

cipla usa inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (who group 1) to improve exercise ability. studies establishing effectiveness included predominately patients with nyha functional class ii – iii symptoms and etiologies of idiopathic or heritable pah (61%) or pah associated with connective tissue diseases (23%). tadalafil tablets are contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. do not use nitrates within 48 hours of the last dose of tadalafil tablets. tadalafil potentiates the hypotensive effect of nitrates.this potentiation is thought to result from the combined effects of nitrates and tadalafil on the nitric oxide/cgmp pathway [see clinical pharmacology (12.2)] . coadministration of gc stimulators such as riociguat with tadalafil tablets is contraindicated. tadalafil may potentiate the hypotensive effects of gc stimulators. tadalafil tablet is contraindicated in patients with a known serious hypersensitivi

Соединенные Штаты - английский - NLM (National Library of Medicine)

dr.reddys laboratories inc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of pulmonary arterial hypertension (pah) (who group 1) to improve exercise ability. studies establishing effectiveness included predominately patients with nyha functional class ii to iii symptoms and etiologies of idiopathic or heritable pah (61%) or pah associated with connective tissue diseases (23%). tadalafil tablets are contraindicated in patients who are using any form of organic nitrate, either regularly or intermittently. do not use nitrates within 48 hours of the last dose of tadalafil tablets. tadalafil potentiates the hypotensive effect of nitrates. this potentiation is thought to result from the combined effects of nitrates and tadalafil on the nitric oxide/cgmp pathway [see clinical pharmacology (12.2)]. coadministration of gc stimulators such as riociguat with tadalafil tablets are contraindicated. tadalafil may potentiate the hypotensive effects of gc stimulators. . tadalafil tablets are contraindicated in patients with a known serious hypersen

Соединенные Штаты - английский - NLM (National Library of Medicine)

aurobindo pharma limited - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil tablets or a

Соединенные Штаты - английский - NLM (National Library of Medicine)

cipla usa inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets o

Соединенные Штаты - английский - NLM (National Library of Medicine)

burel pharmaceuticals, llc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil tablets or a

Соединенные Штаты - английский - NLM (National Library of Medicine)

dr.reddys laboratories inc - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil is used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see clinical studies (14.3)]. administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)]. tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil (tadalafil tablets or adcirca® ). hypersensi

Соединенные Штаты - английский - NLM (National Library of Medicine)

alembic pharmaceuticals limited - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets usp decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets usp beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity t

Соединенные Штаты - английский - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets usp decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets usp beyond 26 weeks is unknown [see clinical studies (14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity t

Соединенные Штаты - английский - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil  tablets are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see clinical studies (14.3) ]. administration of tadalafil to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil was shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology (12.2)] . tadalafil tablets are contraindicated in patients with a known serious hypersensitivity to tadalafil. hypersensitivity reactions have been repor

Соединенные Штаты - английский - NLM (National Library of Medicine)

sunshine lake pharma co., ltd. - tadalafil (unii: 742sxx0ict) (tadalafil - unii:742sxx0ict) - tadalafil tablets, usp are indicated for the treatment of erectile dysfunction (ed). tadalafil tablets, usp are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (bph). tadalafil tablets, usp are indicated for the treatment of ed and the signs and symptoms of bph (ed/bph). if tadalafil tablets, usp are used with finasteride to initiate bph treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil tablets, usp decrease from 4 weeks until 26 weeks, and the incremental benefit of tadalafil tablets, usp beyond 26 weeks is unknown [see clinical studies ( 14.3)] . administration of tadalafil tablets to patients who are using any form of organic nitrate, either regularly and/or intermittently, is contraindicated. in clinical pharmacology studies, tadalafil tablets were shown to potentiate the hypotensive effect of nitrates [see clinical pharmacology ( 12.2)]